Observation of multiple intermediates in α-synuclein fibril formation by singular value decomposition analysis

Biochemical and Biophysical Research Communications

Volumn 355, Issue 2, 2007, Pages 398-403

  Kamiyoshihara, Tomoaki ^a   Kojima, Masaki ^a   Uéda, Kenji ^b   Tashiro, Mitsuru ^c   Shimotakahara, Sakurako ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c MEISEI UNIVERSITY   (Japan)

Author keywords

Synuclein; Fibrillation; Intermediates; Singular value decomposition

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID;

ARTICLE; CIRCULAR DICHROISM; FLUORESCENCE; HUMAN; LEWY BODY; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SPECTROFLUOROMETRY; ULTRAVIOLET SPECTROSCOPY;

ALPHA-SYNUCLEIN; CIRCULAR DICHROISM; HUMANS; PARKINSON DISEASE; SPECTROMETRY, FLUORESCENCE;

EID: 33847103123     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.162     Document Type: Article

References (32)

1. Galvin J.E., Lee V.M., Schmidt M.L., Tu P.H., Iwatsubo T., and Trojanowski J.Q. Pathobiology of the Lewy body. Adv. Neurol. 80 (1999) 313-324
2. Ma Q.L., Chan P., Yoshii M., and Uéda K. Alpha-synuclein aggregation and neurodegenerative diseases. J. Alzheimers Dis. 5 (2003) 139-148
3. Shastry B.S. Neurodegenerative disorders of protein aggregation. Neurochem. Int. 43 (2003) 1-7
4. Tan S.Y., and Pepys M.B. Amyloidosis. Histopathology 25 (1994) 403-414
5. Carrell R.W., and Lomas D.A. Conformational disease. Lancet 350 (1997) 134-138
6. Sunde M., and Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50 (1997) 123-159
7. Uéda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A., Kondo J., Ihara Y., and Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 90 (1993) 11282-11286
8. Davidson W.S., Jonas A., Clayton D.F., and George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273 (1998) 9443-9449
9. Weinreb P.H., Zhen W., Poon A.W., Conway K.A., and Lansbury P.T. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35 (1996) 13709-13715
10. George J.M., Jin H., Woods W.S., and Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15 (1995) 361-372
11. Withers G.S., George J.M., Banker G.A., and Clayton D.F. Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. Brain Res. Dev. Brain Res. 99 (1997) 87-94
12. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A., Kittel A., and Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 (1995) 467-475
13. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
14. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
15. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Llorens V., Gomez Tortosa E., del Ser T., Munoz D.G., and de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55 (2004) 164-173
16. Uversky V.N., Li J., and Fink A.L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 276 (2001) 10737-10744
17. Uversky V.N., and Fink A.L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 1698 (2004) 131-153
18. Uversky V.N. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J. Biomol. Struct. Dyn. 21 (2003) 211-234
19. Giasson B.I., Murray I.V., Trojanowski J.Q., and Lee V.M. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J. Biol. Chem. 276 (2001) 2380-2386
20. Miake H., Mizusawa H., Iwatsubo T., and Hasegawa M. Biochemical characterization of the core structure of alpha-synuclein filaments. J. Biol. Chem. 277 (2002) 19213-19219
21. Hoyer W., Cherny D., Subramaniam V., and Jovin T.M. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry 43 (2004) 16233-16242
22. Spillantini M.G., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
23. Arima K., Uéda K., Sunohara N., Hirai S., Izumiyama Y., Tonozuka-Uehara H., and Kawai M. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res. 808 (1998) 93-100
24. Narhi L., Wood S.J., Steavenson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Martin F., Sitney K., Denis P., Louis J.C., Wypych J., Biere A.L., and Citron M. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274 (1999) 9843-9846
25. Wood S.J., Wypych J., Steavenson S., Louis J.C., Citron M., and Biere A.L. Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J. Biol. Chem. 274 (1999) 19509-19512
26. Alim M.A., Hossain M.S., Arima K., Takeda K., Izumiyama Y., Nakamura M., Kaji H., Shinoda T., Hisanaga S., and Uéda K. Tubulin seeds alpha-synuclein fibril formation. J. Biol. Chem. 277 (2002) 2112-2117
27. Higuchi R., Krummel B., and Saiki R.K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids. Res. 16 (1988) 7351-7367
28. Naiki H., Higuchi K., Hosokawa M., and Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem. 177 (1989) 244-249
29. Kojima M., Tanokura M., Maeda M., Kimura K., Amemiya Y., Kihara H., and Takahashi K. pH-dependent unfolding of aspergillopepsin II studied by small-angle X-ray scattering. Biochemistry 39 (2000) 1364-1372
30. Matsuura H., Shimotakahara S., Sakuma C., Tashiro M., Shindo H., Mochizuki K., Yamaguchi A., Kojima M., and Takahashi K. Thermal unfolding of ribonuclease T1 studied by multi-dimensional NMR spectroscopy. Biol. Chem. 385 (2004) 1157-1164
31. Choi W., Zibaee S., Jakes R., Serpell L.C., Davletov B., Crowther R.A., and Goedert M. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett. 576 (2004) 363-368
32. Uversky V.N., Lee H., Li J., Fink A.L., and Lee S. Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations. J. Biol. Chem. 276 (2001) 43495-43498